Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edimara S Reis

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Developmental Biology|June 4, 2017
Complement component C3aR constitutes a novel regulator for chick eye morphogenesisErika Grajales-Esquivel, Agustin Luz-Madrigal, Jeffrey Bierly, et al.
Journal of Proteome Research|August 17, 2018
Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate PeriodontitisNagihan Bostanci, Kai Bao, Xiaofei Li, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Nature Communications|September 16, 2021
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primatesRobin Schmitz, Zachary W Fitch, Paul M Schroder, et al.
Molecular Immunology|December 8, 2007
Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s geneMariane T Amano, Virgínia P L Ferriani, Marlene P C Florido, et al.
Blood|February 6, 2014
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuriaAntonio M Risitano, Daniel Ricklin, Yijun Huang, et al.
Clinical Immunology (Orlando, Fla.)|April 2, 2020
Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primatesSarah Hughes, Justin Gumas, Rebecca Lee, et al.
Nature Cancer|September 10, 2021
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppressionElena Magrini, Sabrina Di Marco, Sarah N Mapelli, et al.
Circulation|May 27, 2018
Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and ThrombosisReinhard J Sauter, Manuela Sauter, Edimara S Reis, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Developmental Biology|June 4, 2017
Complement component C3aR constitutes a novel regulator for chick eye morphogenesisErika Grajales-Esquivel, Agustin Luz-Madrigal, Jeffrey Bierly, et al.
Journal of Proteome Research|August 17, 2018
Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate PeriodontitisNagihan Bostanci, Kai Bao, Xiaofei Li, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Nature Communications|September 16, 2021
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primatesRobin Schmitz, Zachary W Fitch, Paul M Schroder, et al.
Molecular Immunology|December 8, 2007
Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s geneMariane T Amano, Virgínia P L Ferriani, Marlene P C Florido, et al.
Blood|February 6, 2014
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuriaAntonio M Risitano, Daniel Ricklin, Yijun Huang, et al.
Clinical Immunology (Orlando, Fla.)|April 2, 2020
Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primatesSarah Hughes, Justin Gumas, Rebecca Lee, et al.
Nature Cancer|September 10, 2021
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppressionElena Magrini, Sabrina Di Marco, Sarah N Mapelli, et al.
Circulation|May 27, 2018
Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and ThrombosisReinhard J Sauter, Manuela Sauter, Edimara S Reis, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Pageof 6